You are here: Home » Reuters » News
Business Standard

Indivior files lawsuits against Suboxone generic rivals


By Justin George Varghese(Reuters) - Indivior's U.S. subsidiary has filed lawsuits against firms seeking approval for generic versions of its opioid addiction treatment Suboxone, which generates 80 percent of the drugmaker's revenue. The patent lawsuits were filed against Dr. Reddy's, Allergan Plc's Actavis Laboratories, Endo International's Par Pharmaceutical, Alvogen Pharma US, Teva Pharmaceutical Industries and Mylan NV. The lawsuits allege that these companies have infringed a patent that relates to an oral film containing buprenorphine and naloxone, the key constituents of Suboxone, ...

This article is no longer available in our repository.

There could be multiple reasons for this.

First Published: Fri, September 15 2017. 14:29 IST